GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,000 | -25.0% | 33 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $4,000 | +33.3% | 33 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -99.8% | 33 | -99.8% | 0.00% | -100.0% |
| Q4 2019 | $1,632,000 | +208.5% | 15,613 | +239.4% | 0.17% | +188.1% |
| Q3 2019 | $529,000 | +508.0% | 4,600 | +793.2% | 0.06% | +490.0% |
| Q1 2019 | $87,000 | +45.0% | 515 | -16.3% | 0.01% | +25.0% |
| Q4 2018 | $60,000 | -16.7% | 615 | +48.2% | 0.01% | 0.0% |
| Q3 2018 | $72,000 | 0.0% | 415 | -19.4% | 0.01% | 0.0% |
| Q2 2018 | $72,000 | +53.2% | 515 | +24.1% | 0.01% | +33.3% |
| Q1 2018 | $47,000 | +67.9% | 415 | +93.0% | 0.01% | +100.0% |
| Q4 2017 | $28,000 | +40.0% | 215 | +7.5% | 0.00% | 0.0% |
| Q3 2017 | $20,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $20,000 | -4.8% | 200 | +17.6% | 0.00% | 0.0% |
| Q1 2017 | $21,000 | +10.5% | 170 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $19,000 | – | 170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
| HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
| Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
| TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
| First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
| Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
| OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
| SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |